Novartis Investigative Site

Wangen 88239

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease and Lipoprotein(a), Heart Failure With Reduced Ejection Fraction

Studies at this site

• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early